Fig. 3From: Strategic research agenda for biomedical imagingTheranostics in a patient with a metastatic pancreatic neuroendocrine tumour. a 68Ga-Dotatate-PET scan for staging. b SPECT evaluation after treatment. c End-of-treatment 68Ga-Dotatate-PET scan (courtesy of J. Kunikowska, Warsaw)Back to article page